BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

Antimicrobial Agents and Chemotherapy

Volumn 35, Issue 2, 1991, Pages 305-308

  Richman, D ^a   Rosenthal, A S ^a   Skoog, ^a   M , ^a   Eckner, R J ^a   Chou, T C ^a   Sabo, J P ^a   Merluzzi, V J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ARTICLE; CYTOPATHOGENIC EFFECT; DRUG SCREENING; DRUG SENSITIVITY; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PICORNAVIRUS; PRIORITY JOURNAL;

EID: 0025980022     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.35.2.305     Document Type: Article

References (0)